Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (301)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dendritic Cells
27
2025
136
4.520
 Why?
Ovarian Neoplasms
24
2025
459
4.320
 Why?
Cancer Vaccines
13
2020
78
2.910
 Why?
Immunotherapy
13
2025
244
2.690
 Why?
Th17 Cells
3
2020
27
1.460
 Why?
Antigens, Neoplasm
11
2019
147
1.290
 Why?
Myxoma virus
2
2025
15
1.170
 Why?
Oncolytic Virotherapy
2
2025
21
1.160
 Why?
CD4-Positive T-Lymphocytes
8
2023
164
1.040
 Why?
Oncolytic Viruses
1
2025
13
0.970
 Why?
Uterine Cervical Neoplasms
13
2011
299
0.920
 Why?
Oncogene Proteins, Viral
7
2011
54
0.790
 Why?
Neoplasm Recurrence, Local
3
2020
649
0.740
 Why?
T-Lymphocytes, Regulatory
6
2011
84
0.710
 Why?
T-Lymphocytes, Cytotoxic
12
2013
66
0.680
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
14
0.640
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
78
0.590
 Why?
CD8-Positive T-Lymphocytes
11
2023
132
0.550
 Why?
Neoplasms
4
2019
1325
0.540
 Why?
Antibodies, Monoclonal
5
2019
481
0.540
 Why?
DNA-Binding Proteins
5
2007
422
0.530
 Why?
Interleukin-17
2
2020
35
0.520
 Why?
Adjuvants, Immunologic
4
2025
52
0.500
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
94
0.500
 Why?
Female
43
2025
28171
0.440
 Why?
Ascites
1
2014
32
0.440
 Why?
T-Lymphocytes
5
2017
340
0.440
 Why?
Cell Line, Tumor
14
2025
1470
0.430
 Why?
Immunologic Surveillance
2
2011
10
0.430
 Why?
Cytokines
4
2014
623
0.390
 Why?
Humans
54
2025
52483
0.390
 Why?
Signal Transduction
3
2017
1671
0.390
 Why?
Carcinoma
2
2017
138
0.390
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
43
0.370
 Why?
Immunotherapy, Active
1
2011
4
0.370
 Why?
Serine Endopeptidases
3
2009
50
0.360
 Why?
Cytotoxicity, Immunologic
7
2011
58
0.360
 Why?
Animals
17
2025
13505
0.330
 Why?
Adoptive Transfer
1
2009
29
0.320
 Why?
Immunotherapy, Adoptive
3
2005
166
0.300
 Why?
Interferon-gamma
7
2020
180
0.300
 Why?
Epitopes, T-Lymphocyte
3
2008
26
0.290
 Why?
Mice
10
2025
5949
0.280
 Why?
Lymphocyte Activation
3
2005
172
0.270
 Why?
Papillomavirus Vaccines
1
2007
70
0.260
 Why?
Herpesvirus 4, Human
2
2005
43
0.260
 Why?
Immunodominant Epitopes
2
2008
9
0.260
 Why?
Dependovirus
3
2011
103
0.230
 Why?
Virus Replication
1
2025
150
0.220
 Why?
HLA-A2 Antigen
3
2009
11
0.220
 Why?
Cell Transformation, Viral
1
2003
25
0.210
 Why?
Cell Line, Transformed
1
2003
74
0.210
 Why?
Poxviridae Infections
1
2022
4
0.200
 Why?
Poxviridae
1
2022
7
0.200
 Why?
Interferon Type I
1
2022
27
0.200
 Why?
Cystadenocarcinoma, Serous
5
2009
73
0.190
 Why?
Vaccination
4
2010
298
0.190
 Why?
Papillomavirus E7 Proteins
5
2011
32
0.190
 Why?
Disease-Free Survival
2
2020
460
0.190
 Why?
Interleukin-10
2
2017
84
0.190
 Why?
Receptor, erbB-2
4
2008
80
0.190
 Why?
Genes, MHC Class I
3
2008
11
0.180
 Why?
Testis
2
2011
72
0.180
 Why?
Membrane Proteins
4
2011
335
0.180
 Why?
Injections, Intradermal
1
2020
14
0.180
 Why?
Macrophages
4
2022
379
0.170
 Why?
Immunity, Humoral
1
2020
23
0.170
 Why?
Coculture Techniques
3
2014
144
0.170
 Why?
Flow Cytometry
8
2013
478
0.170
 Why?
Folate Receptor 1
1
2020
27
0.170
 Why?
Cell Movement
2
2019
268
0.170
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
235
0.170
 Why?
Carcinoma, Hepatocellular
1
2022
202
0.170
 Why?
Carcinoma, Lewis Lung
1
2019
9
0.160
 Why?
B-Lymphocytes
5
2017
184
0.160
 Why?
Repressor Proteins
3
2011
155
0.160
 Why?
Melanoma, Experimental
1
2019
40
0.160
 Why?
Self Tolerance
1
2019
1
0.160
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.160
 Why?
Liver Neoplasms
1
2022
333
0.150
 Why?
Transplantation, Autologous
1
2020
488
0.150
 Why?
Aged
12
2020
10121
0.150
 Why?
Cells, Cultured
6
2014
1567
0.140
 Why?
Cytotoxicity Tests, Immunologic
4
2005
26
0.140
 Why?
N-Acetylglucosaminyltransferases
1
2017
14
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2017
41
0.140
 Why?
Receptors, Notch
1
2017
27
0.140
 Why?
HLA Antigens
4
2006
56
0.140
 Why?
Middle Aged
16
2020
13028
0.140
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
99
0.130
 Why?
Neoplastic Stem Cells
1
2017
99
0.130
 Why?
Carcinoma, Papillary
3
2005
51
0.130
 Why?
Poliovirus Vaccine, Oral
2
2005
4
0.120
 Why?
Genetic Vectors
3
2011
128
0.120
 Why?
Poliovirus
2
2005
10
0.120
 Why?
Neoplasm Proteins
1
2017
334
0.120
 Why?
Clinical Trials, Phase I as Topic
1
2015
25
0.120
 Why?
Adult
15
2011
14161
0.120
 Why?
Adenocarcinoma
3
2004
405
0.120
 Why?
Galectin 3
1
2014
14
0.110
 Why?
Antigen Presentation
5
2009
26
0.110
 Why?
Kallikreins
2
2005
19
0.110
 Why?
Neoplasm Invasiveness
3
2017
278
0.110
 Why?
Cystadenocarcinoma, Papillary
2
2005
14
0.110
 Why?
Histocompatibility Antigens Class I
2
2005
48
0.110
 Why?
Peptide Fragments
4
2009
203
0.110
 Why?
Endometrial Neoplasms
2
2005
144
0.110
 Why?
Uterine Neoplasms
2
2005
60
0.110
 Why?
Papillomavirus Infections
3
2011
173
0.100
 Why?
Mutation
1
2019
1347
0.100
 Why?
Mice, Inbred C57BL
3
2017
1884
0.100
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
134
0.100
 Why?
Lymphocytes
1
2013
153
0.100
 Why?
Antigens, Viral
3
2007
43
0.090
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.090
 Why?
Killer Cells, Natural
4
2005
116
0.090
 Why?
rho GTP-Binding Proteins
1
2011
7
0.090
 Why?
Clonal Anergy
1
2011
13
0.090
 Why?
A Kinase Anchor Proteins
1
2011
3
0.090
 Why?
Calmodulin-Binding Proteins
1
2011
10
0.090
 Why?
Antigen-Presenting Cells
1
2011
23
0.090
 Why?
Drug Resistance, Neoplasm
5
2017
326
0.090
 Why?
Antigens, Surface
1
2011
47
0.090
 Why?
Human papillomavirus 16
1
2011
44
0.090
 Why?
Antineoplastic Agents, Alkylating
1
2011
77
0.090
 Why?
Immunity, Cellular
2
2008
64
0.090
 Why?
Uterine Cervical Dysplasia
1
2011
51
0.090
 Why?
Cyclophosphamide
1
2011
171
0.090
 Why?
Prostate
1
2011
116
0.090
 Why?
Diphosphonates
1
2011
92
0.090
 Why?
Imidazoles
1
2011
124
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2011
857
0.080
 Why?
Papillomaviridae
3
2005
105
0.080
 Why?
Phenotype
1
2013
789
0.080
 Why?
Neoplasm Staging
3
2007
772
0.080
 Why?
Gene Expression Profiling
2
2005
1105
0.080
 Why?
K562 Cells
2
2008
42
0.080
 Why?
Carrier Proteins
1
2011
313
0.080
 Why?
Tumor Microenvironment
2
2023
256
0.080
 Why?
CA-125 Antigen
1
2008
16
0.080
 Why?
Immediate-Early Proteins
1
2008
18
0.080
 Why?
Cytomegalovirus
1
2008
29
0.080
 Why?
Green Fluorescent Proteins
1
2008
93
0.070
 Why?
RNA, Messenger
4
2005
1132
0.070
 Why?
Interleukin-4
2
2005
44
0.070
 Why?
Antibody Formation
1
2007
51
0.070
 Why?
Prostatic Neoplasms
1
2011
398
0.070
 Why?
Antibodies, Viral
1
2007
109
0.070
 Why?
Amino Acid Sequence
2
2005
578
0.070
 Why?
RNA Interference
2
2017
181
0.070
 Why?
Molecular Sequence Data
2
2005
778
0.070
 Why?
Ovary
3
2017
107
0.070
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
405
0.070
 Why?
Recombinant Proteins
1
2007
483
0.060
 Why?
Hypersensitivity, Delayed
1
2005
18
0.060
 Why?
Breast Neoplasms
3
2003
1212
0.060
 Why?
Neoplasms, Squamous Cell
1
2005
7
0.060
 Why?
Monocytes
2
2022
130
0.060
 Why?
Electroporation
1
2005
18
0.060
 Why?
Cell Line
4
2010
1030
0.060
 Why?
Poliomyelitis
1
2005
5
0.060
 Why?
Enterotoxins
1
2005
12
0.060
 Why?
Gene Transfer Techniques
1
2005
40
0.060
 Why?
Interleukin-12
1
2005
27
0.060
 Why?
Genes, erbB-2
1
2005
8
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
582
0.060
 Why?
Immunologic Memory
1
2005
31
0.060
 Why?
Antigens, Heterophile
1
2005
1
0.060
 Why?
Plasmodium falciparum
1
2005
26
0.060
 Why?
Burkitt Lymphoma
1
2005
27
0.060
 Why?
Endemic Diseases
1
2005
25
0.060
 Why?
Malaria, Falciparum
1
2005
23
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
32
0.060
 Why?
Gangliosides
1
2004
5
0.060
 Why?
Ascitic Fluid
1
2004
13
0.060
 Why?
Proteins
2
2005
348
0.060
 Why?
Genetic Therapy
1
2005
121
0.060
 Why?
Ovariectomy
1
2004
113
0.060
 Why?
Vaccines, Subunit
1
2004
15
0.060
 Why?
Hysterectomy
1
2004
90
0.060
 Why?
Immunization, Passive
1
2004
29
0.050
 Why?
Interleukin-6
1
2005
278
0.050
 Why?
Clinical Trials as Topic
2
2007
467
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2019
399
0.050
 Why?
Cell Differentiation
2
2004
665
0.050
 Why?
Protein Binding
1
2005
667
0.050
 Why?
Epithelial Cells
1
2005
215
0.050
 Why?
Vesiculovirus
1
2022
6
0.050
 Why?
Vaccinia virus
1
2022
6
0.050
 Why?
Virus Latency
1
2003
53
0.050
 Why?
Host Specificity
1
2022
5
0.050
 Why?
Cell Adhesion Molecules
1
2003
86
0.050
 Why?
Cell Communication
1
2003
71
0.050
 Why?
Nucleotidyltransferases
1
2022
14
0.050
 Why?
Mammals
1
2022
61
0.050
 Why?
Disease Models, Animal
2
2022
1478
0.050
 Why?
Tumor Cells, Cultured
4
2003
460
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
220
0.050
 Why?
Radiotherapy
1
2002
127
0.050
 Why?
Rabbits
1
2022
375
0.050
 Why?
Down-Regulation
1
2003
346
0.050
 Why?
Blood Transfusion
1
2002
127
0.050
 Why?
Disease Progression
2
2019
871
0.050
 Why?
Viral Proteins
1
2022
164
0.040
 Why?
Immunohistochemistry
4
2005
979
0.040
 Why?
Carcinoma, Squamous Cell
1
2004
332
0.040
 Why?
Endothelium
1
2019
37
0.040
 Why?
Transcriptome
1
2022
370
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
61
0.040
 Why?
Gene Expression
3
2008
618
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
1031
0.040
 Why?
Injections, Intraperitoneal
2
2010
57
0.040
 Why?
Tissue Banks
1
2017
9
0.040
 Why?
Mice, Inbred NOD
1
2017
92
0.030
 Why?
STAT3 Transcription Factor
1
2017
85
0.030
 Why?
Antibodies, Monoclonal, Humanized
3
2004
236
0.030
 Why?
Glycosylation
1
2017
106
0.030
 Why?
Tumor Burden
1
2017
136
0.030
 Why?
RNA, Small Interfering
1
2017
213
0.030
 Why?
Multiple Myeloma
1
2011
3049
0.030
 Why?
Protein Processing, Post-Translational
1
2017
153
0.030
 Why?
Kaplan-Meier Estimate
1
2017
483
0.030
 Why?
Lung Neoplasms
1
2002
636
0.030
 Why?
Survival Analysis
2
2010
673
0.030
 Why?
Apoptosis
2
2014
1119
0.030
 Why?
Perforin
2
2005
12
0.030
 Why?
Pore Forming Cytotoxic Proteins
2
2005
11
0.030
 Why?
Neovascularization, Pathologic
1
2014
153
0.030
 Why?
Anti-Bacterial Agents
1
2019
807
0.030
 Why?
Interleukin-2
2
2003
69
0.030
 Why?
Membrane Glycoproteins
2
2005
244
0.020
 Why?
Vaginal Smears
1
2011
28
0.020
 Why?
Organ Specificity
1
2011
115
0.020
 Why?
Prostate-Specific Antigen
1
2011
44
0.020
 Why?
DNA, Viral
1
2011
137
0.020
 Why?
Time Factors
2
2010
2968
0.020
 Why?
Major Histocompatibility Complex
1
2010
13
0.020
 Why?
Prognosis
2
2005
2099
0.020
 Why?
Transduction, Genetic
1
2008
44
0.020
 Why?
Fluorescent Antibody Technique
1
2008
111
0.020
 Why?
Leukocytes, Mononuclear
1
2008
123
0.020
 Why?
Alphapapillomavirus
1
2007
13
0.020
 Why?
T-Lymphocyte Subsets
1
2007
41
0.020
 Why?
Models, Immunological
1
2007
8
0.020
 Why?
Aged, 80 and over
2
2005
3392
0.020
 Why?
Immune Tolerance
1
2007
91
0.020
 Why?
HLA-B Antigens
1
2006
8
0.020
 Why?
Adolescent
2
2011
6739
0.020
 Why?
Clone Cells
1
2006
77
0.020
 Why?
Immunity, Innate
1
2007
117
0.020
 Why?
Male
3
2011
26761
0.020
 Why?
Claudin-3
1
2005
5
0.020
 Why?
Combined Modality Therapy
1
2007
639
0.020
 Why?
Claudin-4
1
2005
7
0.020
 Why?
Mice, Inbred C3H
1
2005
83
0.010
 Why?
Peptides
1
2006
223
0.010
 Why?
Protein Sorting Signals
1
2005
8
0.010
 Why?
Protein Engineering
1
2005
20
0.010
 Why?
Histocompatibility Antigens Class II
1
2005
36
0.010
 Why?
Plasmids
1
2005
163
0.010
 Why?
Species Specificity
1
2005
192
0.010
 Why?
Mice, SCID
1
2005
182
0.010
 Why?
Protein Folding
1
2005
50
0.010
 Why?
Epithelium
1
2004
65
0.010
 Why?
Endocytosis
1
2005
52
0.010
 Why?
Receptors, Cell Surface
1
2005
118
0.010
 Why?
Carboplatin
1
2004
57
0.010
 Why?
Radiotherapy, Adjuvant
1
2004
63
0.010
 Why?
Paclitaxel
1
2004
89
0.010
 Why?
Transfection
1
2005
357
0.010
 Why?
Polymerase Chain Reaction
1
2005
461
0.010
 Why?
Antineoplastic Agents, Hormonal
1
2004
53
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
12
0.010
 Why?
Tumor Stem Cell Assay
1
2003
17
0.010
 Why?
Proportional Hazards Models
1
2005
443
0.010
 Why?
Cervix Uteri
1
2004
49
0.010
 Why?
Up-Regulation
1
2005
454
0.010
 Why?
Swine
1
2005
428
0.010
 Why?
Kinetics
1
2005
626
0.010
 Why?
Keratinocytes
1
2004
93
0.010
 Why?
Receptors, Interleukin-2
1
2002
7
0.010
 Why?
Lymphocyte Subsets
1
2002
14
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
54
0.010
 Why?
Cell Culture Techniques
1
2003
102
0.010
 Why?
Antigens, CD19
1
2002
28
0.010
 Why?
Leukocytes
1
2003
66
0.010
 Why?
Receptors, IgG
1
2002
24
0.010
 Why?
Cell Death
1
2003
177
0.010
 Why?
Doxorubicin
1
2004
241
0.010
 Why?
Immunophenotyping
1
2002
117
0.010
 Why?
Cisplatin
1
2004
285
0.010
 Why?
Survival Rate
1
2005
945
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
46
0.010
 Why?
Tumor Virus Infections
1
2002
48
0.010
 Why?
Fatal Outcome
1
2002
197
0.010
 Why?
Young Adult
1
2011
4329
0.010
 Why?
Cell Division
1
2002
291
0.010
 Why?
Case-Control Studies
1
2004
1201
0.010
 Why?
Prospective Studies
1
2004
2481
0.010
 Why?
Risk Factors
1
2004
3889
0.010
 Why?
Antineoplastic Agents
1
2002
1222
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (301) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department